Survival Outcomes After Heart Transplantation

Author:

Moayedi Yasbanoo12,Fan Chun Po S.2,Cherikh Wida S.3,Stehlik Joseph4,Teuteberg Jeffrey J.1,Ross Heather J.2,Khush Kiran K.1

Affiliation:

1. Section of Heart Failure, Cardiac Transplant, and Mechanical Circulatory Support, Department of Medicine, Stanford University, CA (Y.M., J.J.T., K.K.K.).

2. Ted Rogers Centre of Excellence in Heart Function, Peter Munk Cardiac Centre, University Health Network, Toronto, Canada (Y.M., C.P.S.F., H.J.R.).

3. United Network for Organ Sharing, Richmond, VA (W.S.C.).

4. Department of Medicine, Division of Heart Transplant, University of Utah School of Medicine, Salt Lake City (J.S.).

Abstract

Background: Currently, women represent <25% of heart transplant recipients. Reasons for this female underrepresentation have been attributed to selection and referral bias and potentially poorer outcomes in female recipients. The aim of this study was to compare long-term posttransplant survival between men and women, when matched for recipient and donor characteristics. Methods and Results: Using the International Society for Heart and Lung Transplantation Registry, we performed descriptive analyses and estimated overall freedom from posttransplant death stratified by sex using Kaplan-Meier survival methods. Male and female recipients were matched according to the Index for Mortality Prediction After Cardiac Transplantation and Donor Risk Index score using 1:1 propensity score matching. The study cohort comprised 34 198 heart transplant recipients (76.3% men, 23.7% women) between 2004 and 2014. Compared with men, women were more likely younger (51 [39–59] versus 55 [46–61] years; P <0.001) and had a different distribution of heart failure etiology ( P <0.001). In general, the prevalence of comorbidities was lower in women than in men. Women were less likely to have diabetes mellitus (19.1% versus 26.2%; P <0.001), hypertension (40.7% versus 47.9%; P <0.001), peripheral vascular disease (2.4% versus 3.3%; P =0.002), tobacco use (36.5% versus 52.3%; P <0.001), and prior cardiovascular surgery (38.6% versus 50.7%; P <0.001). Women were more likely to have a history of malignancy (10.5% versus 5.3%; P <0.001), require intravenous inotropes (41.4% versus 37.2%; P <0.001), and were less likely supported by an intra-aortic balloon pump (3.3% versus 3.8%; P =0.03) or durable ventricular assist device (22% versus 31.5%; P <0.001). Transplanted male recipients had a higher Index for Mortality Prediction After Cardiac Transplantation score (5 [2–7] versus 4 [1–6]; P <0.001). When male and female heart transplant recipients were matched for recipient and donor characteristics, there was no significant survival difference ( P =0.57). Conclusions: Overall survival does not differ between men and women after cardiac transplantation. Women who survive to heart transplantation appear to have lower risk features than male recipients but receive hearts from higher risk donors.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3